Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.

Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, Roncalli M, Rudolph KL.

Hepatology. 2007 Apr;45(4):968-76.

PMID:
17393506
2.

p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.

Matsuda Y, Ichida T.

Med Mol Morphol. 2006 Dec;39(4):169-75. Review.

PMID:
17187177
3.

Relevance of hepatic preneoplasia for human hepatocarcinogenesis.

Su Q, Bannasch P.

Toxicol Pathol. 2003 Jan-Feb;31(1):126-33. Review.

PMID:
12597457
4.

Senescence and immortality in hepatocellular carcinoma.

Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H.

Cancer Lett. 2009 Dec 1;286(1):103-13. doi: 10.1016/j.canlet.2008.10.048. Review.

PMID:
19070423
5.

[Precancerous stages of hepatocellular carcinoma].

Tanikawa K.

Gan To Kagaku Ryoho. 1995 Dec;22(14):2055-61. Review. Japanese.

PMID:
8607615
6.

Update on precursor and early lesions of hepatocellular carcinomas.

Park YN.

Arch Pathol Lab Med. 2011 Jun;135(6):704-15. doi: 10.1043/2010-0524-RA.1. Review.

PMID:
21631263
7.

Cell cycle regulation and hepatocarcinogenesis.

Greenbaum LE.

Cancer Biol Ther. 2004 Dec;3(12):1200-7. Review.

PMID:
15662121
8.

Proliferative drive and liver carcinogenesis: too much of a good thing?

Teoh NC.

J Gastroenterol Hepatol. 2009 Dec;24(12):1817-25. doi: 10.1111/j.1440-1746.2009.06121.x. Review.

PMID:
20002941
9.

Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Ohkoshi S, Yano M, Matsuda Y.

World J Gastroenterol. 2015 Nov 14;21(42):12150-6. doi: 10.3748/wjg.v21.i42.12150. Review.

Supplemental Content

Support Center